Skip to main content
Table of Contents
Print

Does Cannabis Use Enhance Emotional Processing During EMDR Therapy for Depression? 

Author: Dr. Clarissa Morton, PharmD

Interest in cannabis and EMDR for depression is growing as patients and clinicians explore new ways to support trauma-related mood disorders. Eye movement desensitisation and reprocessing (EMDR) is a structured form of trauma therapy that helps patients process distressing memories and reduce their emotional weight. Some suggest that cannabis, particularly CBD, may ease anxiety and encourage emotional openness during sessions. 

CBD’s calming properties may help patients feel safer when confronting painful experiences, while small amounts of THC could lower inhibition. However, higher doses of THC risk interfering with concentration and may intensify distress rather than reduce it. 

Cannabis And Emotional Processing 

Studies examining cannabis and EMDR for depression look at whether cannabinoids can improve tolerance for emotional work during therapy. 

Trauma Therapy 

Cannabis may complement trauma therapy by reducing physical symptoms of stress, such as increased heart rate or muscle tension, making it easier for patients to stay engaged. 

Eye Movement Desensitisation 

CBD could support eye movement desensitisation by calming overactive fear responses, helping patients maintain focus on the therapeutic process without becoming overwhelmed. 

Emotional Healing 

Some reports link cannabis to improved emotional healing, as patients describe feeling more open and able to access memories that previously felt blocked. These effects, however, remain highly individual. 

In summary, research into cannabis and EMDR for depression is limited but suggests potential benefits for emotional processing. Careful dosing and professional supervision are essential to ensure safety and effectiveness. 

For patients considering whether cannabis might support EMDR therapy, providers like LeafEase can offer personalised consultations to explore safe and tailored options. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Depression. 

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories